Research Article

Proteomic Profiling for Peritoneal Dialysate: Differential Protein Expression in Diabetes Mellitus

Table 1

The 10 peritoneal dialysate proteins identified with higher confidence levels (at least three unique peptide sequences matched) in this study.

Accession no.Protein nameExpressionMW (Da)PI ValueMascot scoreMatch queriesSequence coveragePeptide

P02768Albumin (ALB)Downregulation693678.266417%K.FQNALLVR.Y
K.AVMDDFAAFVEK.C + oxidation (M)
K.KVPQVSTPTLVEVSR.N

P02760Alpha-1-microglobulin/bikunin preproprotein (AMBP)Downregulation389995.95349721%R.ETLLQDFR.V
K.WYNLAIGSTCPWLK.K + carbamidomethyl (C);
R.GECVPGEQEPEPILIPR.V + carbamidomethyl (C)
R.EYCGVPGDGDEELLRFSN.-
R.VVAQGVGIPEDSIFTMADR.G
R.VVAQGVGIPEDSIFTMADR.G + oxidation (M)
R.ETLLQDFRVVAQGVGIPEDSIFTMADR.G + deamidated (NQ)

P02647Apolipoprotein A-I (APOA1)Downregulation307785.392441244%K.VQPYLDDFQK.K
K.WQEEMELYR.Q + oxidation (M)
R.THLAPYSDELR.Q
K.VQPYLDDFQKK.W
R.DYVSQFEGSALGK.Q
R.VKDLATVYVDVLK.D
K.VEPLRAELQEGAR.Q + deamidated (NQ)
K.VEPLRAELQEGAR.Q
K.LLDNWDSVTSTFSK.L
R.QKVEPLRAELQEGAR.Q + Gln->pyro-Glu (N-term Q)
R.QKVEPLRAELQEGAR.Q
K.DSGRDYVSQFEGSALGK.Q

P01857Immunoglobulin G1 Fc fragment (IGHG1)Downregulation361066.95154536%K.NQVSLTCLVK.G + carbamidomethyl (C)
K.FNWYVDGVEVHNAK.T
R.EPQVYTLPPSRDELTK.N + deamidated (NQ)
R.TPEVTCVVVDVSHEDPEVK.F + carbamidomethyl (C)
R.WQQGNVFSCSVMHEALHNHYTQK.S + carbamidomethyl (C); deamidated (NQ)

P02753Mutant retinol binding protein (RBP4)Downregulation230106.29235484%-.FSGTWYAMAK.K
-.FSGTWYAMAK.K + oxidation (M)
K.KDPEGLFLQDNNVAEFSVDETGQMSATAK.G
K.KDPEGLFLQDNNVAEFSVDETGQMSATAK.G + oxidation (M)

P00738Haptoglobin alpha2 (HP)Downregulation452056.4677421%K.LPECEADDGCPKPPEIAHGYVEHSVR.Y + 2 carbamidomethyl (C)
K.AVGDKLPECEADDGCPKPPEIAHGYVEHSVR.Y + 2 carbamidomethyl (C)
K.LPECEADDGQPPPKCIAHGYVEHSVR.Y + 2 carbamidomethyl (C); deamidated (NQ)
K.AVGDKLPECEADDGQPPPKCIAHGYVEHSVR.Y + 2 carbamidomethyl (C); deamidated (NQ)

P06727Apolipoprotein A-IV (APOA4)Upregulation453995.2311091943%K.VNSFFSTFK.E
R.LTPYADEFK.V
R.LEPYADQLR.T
K.ALVQQMEQLR.Q
R.LTPYADEFKVK.I
K.LVPFATELHER.L
R.DKVNSFFSTFK.E
K.LGEVNTYAGDLQK.K
K.KLVPFATELHER.L
K.VKIDQTVEELRR.S
K.LNHQLEGLTFQMK.K
K.LKEEIGKELEELR.A
K.SELTQQLNALFQDK.L
K.LGPHAGDVEGHLSFLEK.D
K.SLAELGGHLDQQVEEFR.R
R.ENADSLQASLRPHADELK.A
R.QKLGPHAGDVEGHLSFLEK.D
R.ENADSLQASLRPHADELKAK.I

P25311Zn-alpha2-glycoprotein (AZGP1)Upregulation342595.717392448%K.SQPMGLWR.Q
K.CLAYDFYPGK.I + carbamidomethyl (C)
K.WEAEPVYVQR.A
K.AREDIFMETLK.D
K.AYLEEECPATLR.K + carbamidomethyl (C)
K.QKWEAEPVYVQR.A + Gln->pyro-Glu (N-term Q)
K.QKWEAEPVYVQR.A
K.QKWEAEPVYVQR.A + deamidated (NQ)
K.AYLEEECPATLRK.Y + carbamidomethyl (C)
K.YYYDGKDYIEFNK.E
R.QDPPSVVVTSHQAPGEK.K + Gln->pyro-Glu (N-term Q)
R.AKAYLEEECPATLRK.Y + carbamidomethyl (C)
K.EIPAWVPFDPAAQITK.Q
R.QDPPSVVVTSHQAPGEKK.K + Gln->pyro-Glu (N-term Q)
R.QVEGMEDWKQDSQLQK.A + Gln->pyro-Glu (N-term Q)
R.QVEGMEDWKQDSQLQK.A + deamidated (NQ); Gln->pyro-Glu (N-term Q); oxidation
R.QVEGMEDWKQDSQLQK.A
R.QVEGMEDWKQDSQLQK.A + deamidated (NQ)
R.QVEGMEDWKQDSQLQK.A + oxidation (M)
R.QVEGMEDWKQDSQLQK.A + deamidated (NQ); oxidation (M)
K.NILDRQDPPSVVVTSHQAPGEK.K
K.NILDRQDPPSVVVTSHQAPGEK.K + deamidated (NQ)
K.HVEDVPAFQALGSLNDLQFFR.Y
K.NILDRQDPPSVVVTSHQAPGEKK.K

Q04637eukaryotic translation initiation factor 4A isoform 1 (EIF4G1)Upregulation1754915.32469828%R.QFYINVER.E
K.GYDVIAQAQSGTGK.T
K.GVAINMVTEEDKR.T
K.MFVLDEADEMLSR.G
R.DFTVSAMHGDMDQK.E
K.LQMEAPHIIVGTPGR.V
R.GIYAYGFEKPSAIQQR.A
K.LNSNTQVVLLSATMPSDVLEVTK.K

P01892Human class I histocompatibility antigen (HLA-A)Upregulation409226.46129336%R.VNHVTLSQPKIVK.W
K.SNFLNCYVSGFHPSDIEVDLLK.N + carbamidomethyl (C)
K.SNFLNCYVSGFHPSDIEVDLLK.N + carbamidomethyl (C); deamidated (NQ)